Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antibiotics from myxobacteria.

Till F Schäberle1, Friederike Lohr, Alexander Schmitz

  • 1Institute for Pharmaceutical Biology, University of Bonn, Nussallee 6, 53115 Bonn, Germany. till.schaeberle@uni-bonn.de g.koenig@uni-bonn.de.

Natural Product Reports
|May 21, 2014
PubMed
Summary

This review covers antibiotically active compounds from myxobacteria up to 2013. It highlights their diverse structures and biological activities, identifying promising leads for future drug development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vector venom: venomics of Aedes albopictus reveals a large enzyme repertoire and novel cecropins with activity against E. coli.

npj drug discovery·2026
Same author

Strevertene A, a Streptomyces-Derived Macrolide, Reveals Selective Activity against the Human Parasite <i>Schistosoma mansoni</i>.

ACS omega·2026
Same author

Re-investigation of the HExxH enzyme DarF reveals a dehydrogenation-epoxidation reaction.

Organic & biomolecular chemistry·2026
Same author

LC-HRMS-Based Metabolomic Profiling and Antioxidant Activity of <i>Sargassum ilicifolium</i> Under Different Pretreatments, Extraction Methods, and Solvents.

Antioxidants (Basel, Switzerland)·2026
Same author

Microfluidic process-property correlations of dsRNA lipid nanoparticle formulations.

Scientific reports·2026
Same author

Mechanistic profiling and optimized production of Altenusin, a fungal carboxy-biphenyl scaffold for tyrosinase inhibition.

RSC advances·2026

Area of Science:

  • Microbiology
  • Natural Product Chemistry
  • Pharmacology

Background:

  • Myxobacteria are prolific producers of structurally diverse natural products.
  • Many of these natural products exhibit significant biological activities, particularly antibiotic properties.
  • Understanding these compounds is crucial for discovering new therapeutic agents.

Purpose of the Study:

  • To review and assess antibiotically active compounds produced by myxobacteria up to the end of 2013.
  • To describe the structural diversity and biological potential of these compounds.
  • To identify promising lead structures for future research and potential clinical applications.

Main Methods:

  • Comprehensive literature search for myxobacterial compounds with antibiotic activity published up to 2013.

Related Experiment Videos

  • Analysis of structural diversity and reported biological activities.
  • Evaluation of identified compounds as potential lead structures.

    • Main Results:

    • Identification of a wide array of structurally distinct myxobacterial compounds with antibiotic activity.
    • Detailed description of their particularities and, where known, their modes of action.
    • Assessment of their potential for further investigation and clinical use.

    Conclusions:

    • Myxobacteria represent a rich source of novel antibiotic compounds.
    • Specific myxobacterial compounds show significant potential as lead structures for drug discovery.
    • Further investigation into these compounds could lead to new clinical applications.